Evaluation of age-related differences in the immunogenicity of a G9 H9N2 influenza vaccine
about
Vaccines for preventing influenza in healthy adultsBroadly protective adenovirus-based multivalent vaccines against highly pathogenic avian influenza viruses for pandemic preparedness.Phase I/II randomized double-blind study of the safety and immunogenicity of a nonadjuvanted vero cell culture-derived whole-virus H9N2 influenza vaccine in healthy adults.Seroprevalence of antibodies to avian influenza A (H5) and A (H9) viruses among market poultry workers, Hanoi, Vietnam, 2001.Adenovirus vector-based multi-epitope vaccine provides partial protection against H5, H7, and H9 avian influenza viruses.Reply to Pawar et al.
P2860
Evaluation of age-related differences in the immunogenicity of a G9 H9N2 influenza vaccine
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Evaluation of age-related diff ...... of a G9 H9N2 influenza vaccine
@ast
Evaluation of age-related diff ...... of a G9 H9N2 influenza vaccine
@en
type
label
Evaluation of age-related diff ...... of a G9 H9N2 influenza vaccine
@ast
Evaluation of age-related diff ...... of a G9 H9N2 influenza vaccine
@en
prefLabel
Evaluation of age-related diff ...... of a G9 H9N2 influenza vaccine
@ast
Evaluation of age-related diff ...... of a G9 H9N2 influenza vaccine
@en
P2093
P2860
P1433
P1476
Evaluation of age-related diff ...... of a G9 H9N2 influenza vaccine
@en
P2093
Diane Nino
Heather Hill
Janet Wells
John M Quarles
Nancy Arden
Robert B Couch
Shital M Patel
Thomas R Cate
P2860
P304
P356
10.1016/J.VACCINE.2011.08.044
P407
P577
2011-08-22T00:00:00Z